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Key statistics
  In 2000, 90% of the societal cost of depression was due 
to unemployment and absenteeism.1
  In 2000, the service costs associated with childhood 
psychiatric disorders were 12 times greater for frontline 
education services than for specialist mental health 
services.2
  Over 25 years, the total return from parenting programmes 
for children with conduct disorder is between 2.8 and 6.1 
times the intervention cost, much of this through reduced 
crime.3
  Early intervention services that provide intensive support 
for young people experiencing a first psychotic episode can 
help avoid substantial health and social care costs: over 
10 years perhaps £15 in costs can be avoided for every 
£1 invested.4
  £1 in every £8 spent in England on long-term conditions is 
linked to poor mental health.5
  More than 11% of the NHS budget is spent on 
treating mental illness6 – but the indirect costs from 
unemployment, absenteeism and presenteeism can 
be higher. These indirect costs totalled £30.3 billion in 
England in 2009/10 across all mental illnesses, compared 
with direct health and social care costs of £21.3 billion.7
  The economic cost of a completed suicide for someone of 
working age in the UK exceeds £1.6 million.8
Overview
Mental illness can emerge at any age, and can have highly 
significant impacts across much of the life course for the 
individual, their family and community. Those impacts may 
start early in life – maternal mental illness can negatively 
affect a child’s later emotional, behavioural and intellectual 
development – or may strike late; for example, the 
consequences of bereavement can last many years.
Emotional and behavioural problems that develop in 
childhood can leave a legacy of difficulties that stretches 
long into adulthood. The typical age of onset of serious 
psychoses such as schizophrenia and bipolar disorder – in 
late adolescence and early adulthood – is also the time when 
many key investments and decisions are made that shape 
future careers, personal and social roles.
People with mental health problems are more likely to smoke, 
be overweight, have disrupted education, be unemployed, 
take time off work, fall into poverty, and find themselves in 
the criminal justice system. Major mental disorders shorten 
the life span. As other chapters in this report make clear, and 
as we describe below, no field of social policy is untouched 
by mental illness.
While it is the health and quality of life consequences of 
mental illness that rightly dominate public concerns,9 it is the 
economic consequences that most heavily influence policy 
responses. This is not because the dominant policy aim 
for public mental health is to save resources, but because 
those people who make, shape and implement policies 
recognise that those resources are always scarce relative 
to the demands made upon them – especially so when 
there are broader economic pressures.10 Decision makers 
want preventive strategies and treatment approaches to be 
effective in improving health and quality of life, but they also 
want to get good value for money.
We address this value for money question by examining 
the economic case for better public mental health. Making 
the economic case does not mean cutting costs but rather 
using resources (not just in the NHS, but across the whole 
economy) to their best effect – making sure they are used to 
get the best achievable health and quality of life outcomes. 
We discuss a series of economic opportunities and challenges. 
Between them, they reflect the key characteristics of mental 
health problems: distressing and disabling symptoms; 
chronicity if untreated; high rates of co-morbidity; effects on 
many aspects of individuals’ lives; spillover effects on families 
and communities; disrupted employment; associations 
with anti social behaviour and crime; links to self-harm and 
suicide; widespread stigma, discrimination and victimisation; 
and interconnections with socio-economic disadvantage and 
inequalities. We shall demonstrate how economic arguments 
can support the case for prevention and treatment.
Making an economic case
Scarcity and choice
Healthcare and other responses to the needs of people with 
mental health problems that are well designed, well co-
ordinated and well targeted will have significant impacts on 
their symptoms, functioning and quality of life, and may also 
improve the quality of life of family members and others. 
The problem is that there are never enough health or other 
services to meet all needs or satisfy all preferences. This 
endemic scarcity leads to difficult decisions about how best 
to achieve good clinical and quality of life outcomes, in turn 
raising questions about how to use resources efficiently and 
equitably – criteria that we define below. These are moral, 
political and perhaps even ethical questions; but they are also 
economic questions.
A simple framework (Figure 9.1) shows common interventions 
(shorthand for treatments, support arrangements, preventive 
strategies or wider policy frameworks), their potential 
health and other outcomes, and the consequences of those 
outcomes for resource use patterns and costs. Interventions 
that improve outcomes may reduce longer-term costs: 
for example, treating the early signs of psychosis could 
reduce positive symptoms and keep patients engaged in 
education or employment, thereby avoiding the need for 
inpatient admissions (or shortening their duration) and 
reducing productivity losses from absenteeism or long-term 
unemployment.4
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Figure 9.1 also shows how economic analysis helps us 
understand and improve mental health systems (see also 
World Health Organization, 2006).11 There are four questions 
that economists often address. Cost questions focus on 
the resources used to provide treatment, care and support. 
Cost-offset questions ask how those costs compare with 
the savings resulting from successful treatment or prevention. 
Cost-effectiveness questions ask about links between the 
resources expended and the outcomes achieved. Incentives 
questions address ways to encourage decision makers to 
pursue policies or practices that are effective, efficient 
and fair.
Cost-effectiveness
The cost-effectiveness question is the most relevant, and 
embodies the cost and cost-offset questions. For two or 
more interventions or strategies (one of which could be 
doing nothing), a cost-effectiveness analysis compares the 
resources used by each (the costs) with the health, quality 
of life or other outcomes achieved (the effectiveness). If one 
intervention has both lower costs and greater effectiveness 
than the other, it will look attractive to hard-pressed budget-
holders, although their ultimate decisions will also factor in 
fairness and other wider strategic considerations. However, if 
one intervention is more effective than the other but only at a 
higher cost, then someone must decide whether those better 
outcomes are worth the additional expenditure.12,13 There 
is no simple way to judge such ‘worth’: it is in the eye of 
the beholder, and different beholders might reach different 
judgements.
An intervention does not need to save money to be cost-
effective. However, it does need to generate outcomes that 
are ‘worth’ paying for, which means that the outcome gains 
are greater than would be achieved by using the resources 
in any other way. Someone must weigh up the relative 
outcomes and costs, and make the trade-off. Politicians 
are elected to make these decisions strategically, and 
commissioners and providers are entrusted with responsibility 
locally. Each can be guided by evidence from well-conducted 
research and also (in England and Wales) by the National 
Institute for Health and Care Excellence (NICE), which 
synthesises evidence and combines it with expert advice to 
produce clinical guidelines. These guidelines (for example, on 
depression, psychosis and schizophrenia)14,15 are increasingly 
the mainstay of commissioning and provision across many 
clinical areas, and build explicitly on economic evidence.
Where possible, NICE uses a generic health outcome measure 
– the quality-adjusted life year (QALY) – alongside disease-
specific measures. The QALY is intended for use across all 
clinical areas, allowing broad resource allocation decisions 
to be made. NICE also recommends a threshold value: an 
intervention that costs more than £30,000 per QALY is 
unlikely to be considered ‘worth it’ because it is believed 
Figure 9.1 Mental health – economic questions
INTERVENTION
(medication, psychological 
therapies, community health 
care, home care, telecare)
OUTCOMES
(severity of the condition, behaviour 
change, activities of daily living, social 
interactions, quality of life, carers’ 
quality of life, safety)
COST SAVINGS
(health and social care services, 
educational services, criminal justice 
services, welfare benefits, carers)
Source Martin Knapp, London School of Economics and Political Science
2. 
COST-EFFECTIVENESS?
3. 
COST-OFFSETS?
4. 
INCENTIVES?
1. 
COST?
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that the money could be better spent elsewhere in the NHS 
(NICE, 2008). This approach works less well in areas such as 
schizophrenia, where QALYs are hard to measure reliably,16 
and often needs adaptation in public health and social care 
contexts where health improvement is not the only or even 
the most important objective.
Evidence on cost-effectiveness can be generated from various 
study designs. The randomised controlled trial (RCT) is usually 
best, but observational designs have also been used17 and 
mathematical or statistical modelling is now widely employed 
to supplement and extend RCT findings.18 Modelling also 
offers a short-term substitute for an RCT when decision 
makers need evidence sooner than a trial can deliver – such 
as when projecting the economic impact of closing a hospital 
from data on early discharges into the community19 – and 
also an alternative when a trial is infeasible, such as when 
evaluating a nation-wide policy.20
Cost-effectiveness analyses helpfully remind everyone – 
health professionals, patients, carers, taxpayers and voters 
– that resources are finite and so commissioners and other 
key decision makers face difficult choices in deploying them. 
Those analyses also tell us that it is sometimes worthwhile to 
choose an option even when it does not save money.
Efficiency and equity
Cost-effectiveness and related analyses address questions 
of efficiency: how to get the maximum effect in terms of 
outcomes achieved from a specified volume of resources 
(such as the available budget). Efficiency is not the only 
objective of a healthcare system or nation, of course. Another 
important objective is equity, which relates to the extent to 
which outcomes, access to services and payments for them 
are distributed fairly across individuals, regions or socio-
economic strata. Different people will have different views 
on what is fair, but most would agree that equity should not 
mean exact equality: people have different needs and an 
equitable allocation of resources should result in giving more 
treatment and support to those with greater needs. Similarly, 
individuals have different income and wealth levels, and 
most countries expect those who are better off to contribute 
greater amounts (for example, through taxes for the UK’s 
centrally funded NHS).
Most mental health systems are neither efficient nor 
equitable: they do not get the most out of available 
resources, and they would not be considered by most citizens 
to be distributing their benefits or burdens in ways that are 
fair.21–23
Economic opportunities 
and challenges
Distress and disability
The Global Burden of Disease Study 2010 reports ‘the striking 
and growing challenge that [mental] disorders pose for health 
systems in developed and developing regions’.24 Specifically 
for the UK, figures for 2010 show ‘the growing burden 
of disability, particularly from mental disorders, substance 
use, musculoskeletal disorders, and falls [which] deserve an 
integrated and strategic response’.25
Economists also measure the consequences of mental 
health problems using cost rather than disability weights, 
summing the costs of services and treatments, reductions in 
productivity from disrupted employment, the imputed values 
of unpaid care, and lost economic value from premature 
mortality. The resultant figures do not provide guidance on 
how to prevent or treat illness, but help by emphasising to 
decision makers the scale of the challenge and its distribution 
across the economy.26 For example, Thomas and Morris1 
calculated that 90% of the societal cost of depression was 
due to unemployment and absenteeism, and Snell et al.2 
showed how the service costs associated with childhood 
psychiatric disorders were 12 times greater for frontline 
education services than for specialist mental health services.
Enduring impacts
Mental health problems in childhood or adolescence can have 
later-life consequences: antisocial and criminal behaviour, 
substance misuse, unemployment, social exclusion, emotional 
disorder and poor quality of life (see Chapter 6 of this report, 
‘Life course: children and young people’s mental health’). 
Each of these has attendant costs.27–29 Evidence suggests 
that NHS-delivered interventions in childhood could have 
substantial longer-term impacts, although their biggest 
economic pay-offs may be outside the NHS. Bonin et al.3 
calculated that, over 25 years, the total return from parenting 
programmes for children with conduct disorder is between 
2.8 and 6.1 times the intervention cost, much of this through 
reduced crime. Beecham30 reviews related economic evidence.
The onset of psychosis in adolescence or early adulthood 
can seriously disrupt education and post-school training, 
causing poor educational outcomes and poor employment 
prospects. Leaving the psychosis untreated exacerbates the 
situation and raises the risk of suicide (see Chapter 15 of this 
report, ‘Suicide and self-harm’). Early intervention services 
that provide intensive support for young people experiencing 
a first psychotic episode can reduce relapse rates and improve 
both vocational recovery and quality of life.31,32 They help 
avoid substantial health and social care costs: over 10 years 
perhaps £15 in costs can be avoided for every £1 invested.4
The chronicity of most mental health problems and the 
potential for long-term deleterious impacts across many 
life domains should be enough to energise searches by all 
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interested parties for early effective action – but, as we have 
illustrated, there is also often a supportive economic case. 
A major challenge that we would identify is how to get 
decision makers to think long term, even with short-term 
resource pressures arising from the need to keep within tight 
expenditure constraints.
Co-morbidities
People with schizophrenia and psychosis have higher risks of 
physical morbidity and premature mortality, linked particularly 
to poor health behaviours. Yet they also have poorer access 
to routine health checks (see Chapter 13 of this report, 
‘Physical health and mental disorder’). There are economic 
as well as clinical and ethical reasons for recognising 
and responding to these links, since poor physical health 
translates into increased and enduring NHS costs.
Evidence on the economic case for action is modest but 
accumulating, as we now illustrate. Adding bupropion to 
cognitive behavioural therapy (CBT) and nicotine replacement 
therapy can help people with first-episode psychosis to quit 
smoking and appears to be cost-effective.33 A combination of 
psycho-education and nutritional and/or exercise counselling 
appears to be a cost-effective way to help people with 
first-episode psychosis to manage their weight,34 while a six-
month manualised healthy lifestyle programme appears cost-
effective as a means of managing body mass index for people 
who have been living with schizophrenia for longer.35
Depression is also commonly associated with poor physical 
health (see Chapter 13 of this report, ‘Physical health and 
mental disorder’). Compared with people with diabetes 
alone, those with co-morbid depression and diabetes are four 
times more likely to have difficulties managing their health, 
and seven times more likely to miss work frequently.36 The 
economic consequences for health and other sectors can 
be considerable,37 although ‘collaborative care’ delivered in 
primary care settings to individuals with this co-morbidity 
(involving GP advice and care, antidepressants and sometimes 
CBT, with a practice nurse as case manager) appears to be 
cost-effective.38
More broadly, given that many people with poor long-
term physical health also have mental health problems, the 
resultant NHS costs can be substantial. Naylor et al. (2012) 
conservatively estimated that £1 in every £8 spent in England 
on long-term conditions is linked to poor mental health.5
There are also close links between such co-morbidities and 
deprivation, thereby exacerbating the inequalities between 
socio-economic groups if treatment is not offered. As well as 
collaborative care arrangements, innovative forms of liaison 
psychiatry in acute hospitals can be cost-effective.39 Better 
integration of physical and mental health care, encouraged 
by redesigned payment mechanisms, would further improve 
healthcare quality and productivity.
Figure 9.2 Mental health – multiple needs and impacts
Notes * Economic factors 
Source Martin Knapp, London School of Economics and Political Science
Genes
Family
Employment*
Income*
Trauma
Resilience
Social context
Health care
Social care
Education
Criminal justice
Housing
Employment
Welfare benefits
Carers
 
 
 
 
Department of Health
Department for Education
Home Office
Ministry of Justice
Department for 
Communities and 
Local Government
Department for 
Work and Pensions
Voluntary sector
Carers 
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Multiple needs and impacts
Mental health problems can generate major and enduring 
impacts, and these can be experienced across many aspects 
of an individual’s life, generating needs for support from 
(potentially) the social care, housing, employment, criminal 
justice, income support and other systems (Figure 9.2).7,40–42 
The direct treatment costs to the NHS are certainly substantial 
– more than 11% of the NHS budget is spent on treating 
mental illness6 – but the indirect costs can be even higher. 
Indirect costs – mainly from unemployment, absenteeism 
and presenteeism – amounted to £30.3 billion in England in 
2009/10, compared with direct health and social care costs of 
£21.3 billion.7
One obvious corollary is the need for co-ordinated action 
across budgets and systems to avoid gaps and wasteful 
overlaps, combining resources effectively and efficiently.43 
Silo budgeting – where budget-holders are so determined 
to keep their own spending in check that they engage in 
cost-shifting and problem-dumping onto other budgets – is a 
substantial barrier to better overall efficiency. Silo budgeting 
is likely to be more common when resources are under 
considerable pressure, and yet the greater those pressures, 
the stronger the need for co-ordinated action across different 
areas. A recent, far-sighted example is the decision by a police 
commissioner in England to invest in psychologist-delivered 
parent training programmes to tackle conduct disorder 
because of the potential to cut antisocial behaviour and 
crime-related costs over future decades, as demonstrated by 
Bonin et al.3 Another example is investment in workplace-
based mental illness prevention and treatment programmes 
by some larger companies (and some public sector 
employers), with the potential to reduce both absenteeism 
(thereby improving productivity) and NHS costs.44 Great 
strides have also been made in supporting people with a 
history of severe mental health problems to achieve open 
employment, with cost-effectiveness gains.38
Impacts on others
Mental health problems experienced by expectant and 
new mothers can have deleterious consequences for their 
partners and children, some with measurable associated 
costs.45,46 Behavioural problems in schools can damage the 
education experience for other pupils. The relatives of people 
with schizophrenia may give up employment, take time off 
work to provide support (thereby losing earnings) or give 
up leisure time or incur out-of-pocket costs to subsidise 
treatment expenses or provide transport to appointments. 
These are largely hidden costs, but to overlook them in policy 
discussions would be dangerous given that many people with 
mental health problems rely on their family members and 
communities for support.
Population ageing makes this an especially important issue, 
since models of treatment and care that are reliant primarily 
on paid professionals may not be affordable in future 
decades.
Interventions can be targeted on family members or intra-
family relations, as with family therapy for schizophrenia, for 
which there is both a clinical and an economic case.35,47 Some 
interventions can be justified not only by their effects on 
those individuals who are ill, but also because they recognise 
and address the spillover effects of mental illness on other 
people: for example, CBT and person-centred treatment 
for postnatal depression can have benefits that go beyond 
symptom relief for mothers so as also to improve the lives 
of their children, and in a cost-effective way.48 There are 
also interventions that build explicitly on community assets, 
as with befriending programmes,49,50 and interventions that 
can employ people with lived experience of mental illness to 
deliver support, as with peer workers.51,52
Employment
There are multiple and two-way links between mental 
health problems and employment difficulties. People with a 
history of mental illness are at greater risk of unemployment, 
job insecurity, early retirement, absenteeism, presenteeism 
and low salaries, while stress, bullying and other adverse 
workplace experiences are risk factors for the onset or 
exacerbation of common mental disorders (see Chapter 10).
Employment generates earnings, brings social status, shapes 
social roles, fosters social participation and is a major factor 
in self-image and self-esteem. Long-term unemployment 
increases the risk of unmanageable personal debt and 
poverty, in turn further worsening mental health.53 Most 
people with a history of mental illness want to work, are 
perfectly capable of working in appropriate settings, and 
derive therapeutic benefits from working.44,54 But those 
people often face barriers: reduced abilities because of their 
symptoms (even if only temporarily), endemic social stigma 
and widespread discrimination by employers.
Economic hardship intensifies the difficulties that people 
with mental health problems encounter in the labour market. 
A study that looked at experiences across 27 countries of 
the European Union found that it was harder for people 
with mental health problems to get employment during 
the worldwide macroeconomic recession of recent years 
than people without such morbidity. Moreover, the relative 
disadvantage was significantly greater in countries with 
higher levels of stigmatising attitudes towards mental illness.55
Antisocial behaviour and crime
While, as Howard and Shaw argue in Chapter 14 of this 
report, ‘Violence and mental health’, “most people with 
mental illness are not violent and most people who are 
violent are not mentally ill”, mental health problems may lead 
to contact with the criminal justice system. As noted earlier, 
childhood mental health problems can lead to teenage 
delinquency and adulthood crime.27,29 Economic impacts 
include costs associated with the victim, fear of crime, the 
impacts on the criminal justice system of acquisitive crime by 
people who misuse substances56 and violent crime by people 
experiencing florid psychotic episodes,57 and suicide and self-
harm by people experiencing severe depression.58–60
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Economic evidence in this area is limited. Parenting 
programmes targeted at parents of children with conduct 
disorder and intervention services for those in the early stages 
of psychosis look like cost-effective preventive strategies over 
both the short and long term.3,4 However, little is known 
about the economic case for liaison and diversion services or 
mental health programmes within prisons.61
Suicide and self-harm
Suicide and self-harm are rare but disturbing consequences of 
mental illness. Although not uppermost in decision makers’ 
minds when considering how to address these events, 
there are actually quite high economic consequences too, 
including intangible costs (the value of lost life; pain and 
suffering for relatives), as well as the costs of lost productivity 
(both waged and unwaged), police time and funerals. The 
cost of a completed suicide for someone of working age 
in the UK exceeds £1.6 million.8 Self-harm and non-fatal 
suicide attempts generate costs for Accident & Emergency 
departments and medical, surgical and psychiatric care.62
Although the economic evidence is sparse, there is some to 
guide commissioners. Suicide awareness training for GPs and 
other professionals, followed by CBT for individuals identified 
as at risk, is highly effective in reducing premature death, self-
harm, grief to families and productivity losses. It is also highly 
cost-effective.38 Manual-assisted CBT for adults with a history 
of recurrent deliberate self-harm is also cost-effective,59 but 
group therapy for adolescents who repeatedly self-harm 
is not.63
Stigma and discrimination
Poor mental health can be exacerbated by social exclusion, 
discrimination and prejudice.64 The stigma experienced 
by many people can affect multiple aspects of their lives, 
limiting access to employment and housing, harming 
social relationships, lowering self-esteem and reducing the 
likelihood that they seek treatment.65 Initiatives such as 
England’s Time to Change – which included an anti-stigma 
social marketing campaign – have been launched to try to 
improve public knowledge, attitudes and behaviour. Time 
to Change was found to have a modest but statistically 
significant positive impact, to cost relatively little and to be 
potentially cost-effective.66 Earlier modelling obtained similar 
economic results for the Scottish See Me campaign.20
Inequalities
Unemployment, low income, unmanageable debt, housing 
problems and social deprivation can lead to or exacerbate 
mental and physical health problems, suicide rates, alcohol 
misuse and social isolation, as well as reducing resilience.67 
But there are also causal links in the other direction: 
people with mental health problems are at elevated risk of 
unemployment, early retirement, rent arrears and other debt, 
lower personal and household income and social isolation.53,68
One implication of these connections is the need to pay 
particular attention to mental health needs during periods 
of macroeconomic downturn.69 Another implication is 
that there are wide and deep-rooted inequalities in the 
incidence and prevalence of mental health needs. Income-
related inequalities in mental health are much greater than 
in physical health,21 and are even greater in some minority 
ethnic groups.70
Decision makers should be alert to the possibility that access 
to treatments (and hence to their therapeutic benefits) may 
be inequitably distributed by ethnicity, gender, age, language, 
religion, income or place of residence.68 They should also be 
aware that interventions might be differentially beneficial: 
Barrett et al.71 found that adding joint crisis plans to usual 
treatments was cost-effective in preventing compulsory 
hospital admissions among black patient groups, but not 
among white or Asian groups. As we argued earlier, the 
potential lifelong disadvantages associated with mental 
health problems require long-term strategic action.
Conclusions
Although there is less economic evidence in the mental 
health field than is needed to support the more efficient 
and more equitable allocation of available societal resources, 
the situation is vastly better than even 10 years ago, thanks 
in large measure to publicly funded research in England. 
Strategic decision makers and local commissioners now 
have much more and better evidence to guide their actions. 
Whether they make best use of that evidence is perhaps 
another matter. Efforts are needed to improve the translation 
and implementation of knowledge, to counter some deep-
seated stigmatising attitudes towards mental illness and 
the people who experience it, and to address shortages of 
suitably trained professionals (such as psychologists). Efforts 
are also needed to engage actors across many sectors – not 
just health, but social care, housing, education, employment, 
criminal justice, welfare and so on – given the complex 
aetiology and wide-ranging impacts of many mental health 
problems.
Spending on evidence-based mental health services is 
an investment that will pay quality of life and economic 
dividends across much of society, over many years.
Authors’ suggestions for policy
  The potential lifelong disadvantages associated with 
mental health problems require long-term strategic action.
  Better integration of physical and mental health care, 
encouraged by redesigned payment mechanisms, would 
further improve healthcare quality and productivity.
  National and local efforts are needed to address persistent 
negative attitudes towards mental illness, particularly 
towards schizophrenia and other psychoses.
  Access to treatments (and hence to their therapeutic 
benefits) may be inequitably distributed by ethnicity, 
gender, age, language, religion, income or place of 
residence.
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